BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 26507673)

  • 1. Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrier.
    Chapy H; Saubaméa B; Tournier N; Bourasset F; Behar-Cohen F; Declèves X; Scherrmann JM; Cisternino S
    Br J Pharmacol; 2016 Feb; 173(3):497-510. PubMed ID: 26507673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice.
    Biali ME; Auvity S; Cisternino S; Smirnova M; Hacker M; Zeitlinger M; Mairinger S; Tournier N; Bauer M; Langer O
    Mol Pharm; 2023 Nov; 20(11):5877-5887. PubMed ID: 37883694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inner Blood-Retinal Barrier Dominantly Expresses Breast Cancer Resistance Protein: Comparative Quantitative Targeted Absolute Proteomics Study of CNS Barriers in Pig.
    Zhang Z; Uchida Y; Hirano S; Ando D; Kubo Y; Auriola S; Akanuma SI; Hosoya KI; Urtti A; Terasaki T; Tachikawa M
    Mol Pharm; 2017 Nov; 14(11):3729-3738. PubMed ID: 28954515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polyspecific drug/proton antiporter mediates diphenhydramine and clonidine transport at the mouse blood-retinal barrier.
    Chapy H; André P; Declèves X; Scherrmann JM; Cisternino S
    Br J Pharmacol; 2015 Oct; 172(19):4714-25. PubMed ID: 26177775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein.
    Lee YJ; Kusuhara H; Jonker JW; Schinkel AH; Sugiyama Y
    J Pharmacol Exp Ther; 2005 Jan; 312(1):44-52. PubMed ID: 15448171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy.
    Tagami M; Kusuhara S; Honda S; Tsukahara Y; Negi A
    Brain Res; 2009 Aug; 1283():186-93. PubMed ID: 19505448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of P-glycoprotein on blood-retinal barrier permeability: comparison of blood-aqueous humor and blood-brain barrier using mdr1a knockout rats.
    Fujii S; Setoguchi C; Kawazu K; Hosoya K
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4650-8. PubMed ID: 24985475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP.
    Römermann K; Wanek T; Bankstahl M; Bankstahl JP; Fedrowitz M; Müller M; Löscher W; Kuntner C; Langer O
    Nucl Med Biol; 2013 Oct; 40(7):873-8. PubMed ID: 23845421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.
    Cisternino S; Mercier C; Bourasset F; Roux F; Scherrmann JM
    Cancer Res; 2004 May; 64(9):3296-301. PubMed ID: 15126373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.
    Cattelotte J; Tournier N; Rizzo-Padoin N; Schinkel AH; Scherrmann JM; Cisternino S
    J Neurochem; 2009 Feb; 108(3):767-75. PubMed ID: 19067785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carrier-mediated Transport of Cationic Drugs across the Blood-Tissue Barrier].
    Kubo Y
    Yakugaku Zasshi; 2015; 135(10):1135-40. PubMed ID: 26423869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of carrier-mediated transport in the retinal uptake of clonidine at the inner blood-retinal barrier.
    Kubo Y; Tsuchiyama A; Shimizu Y; Akanuma S; Hosoya K
    Mol Pharm; 2014 Oct; 11(10):3747-53. PubMed ID: 25222277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An electrically tight in vitro blood-brain barrier model displays net brain-to-blood efflux of substrates for the ABC transporters, P-gp, Bcrp and Mrp-1.
    Helms HC; Hersom M; Kuhlmann LB; Badolo L; Nielsen CU; Brodin B
    AAPS J; 2014 Sep; 16(5):1046-55. PubMed ID: 24934296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone.
    Kodaira H; Kusuhara H; Ushiki J; Fuse E; Sugiyama Y
    J Pharmacol Exp Ther; 2010 Jun; 333(3):788-96. PubMed ID: 20304939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raltegravir permeability across blood-tissue barriers and the potential role of drug efflux transporters.
    Hoque MT; Kis O; De Rosa MF; Bendayan R
    Antimicrob Agents Chemother; 2015 May; 59(5):2572-82. PubMed ID: 25691630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of a novel organic cation transporter in verapamil transport across the inner blood-retinal barrier.
    Kubo Y; Kusagawa Y; Tachikawa M; Akanuma S; Hosoya K
    Pharm Res; 2013 Mar; 30(3):847-56. PubMed ID: 23179781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium.
    Swed A; Eyal S; Madar I; Zohar-Kontante H; Weiss L; Hoffman A
    Mol Pharm; 2009; 6(6):1883-90. PubMed ID: 19722701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate.
    Kodaira H; Kusuhara H; Fujita T; Ushiki J; Fuse E; Sugiyama Y
    J Pharmacol Exp Ther; 2011 Dec; 339(3):935-44. PubMed ID: 21934030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioids and the Blood-Brain Barrier: A Dynamic Interaction with Consequences on Drug Disposition in Brain.
    Chaves C; Remiao F; Cisternino S; Decleves X
    Curr Neuropharmacol; 2017 Nov; 15(8):1156-1173. PubMed ID: 28474563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier-Mediated Transport of Nicotine Across the Inner Blood-Retinal Barrier: Involvement of a Novel Organic Cation Transporter Driven by an Outward H(+) Gradient.
    Tega Y; Kubo Y; Yuzurihara C; Akanuma S; Hosoya K
    J Pharm Sci; 2015 Sep; 104(9):3069-75. PubMed ID: 25892000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.